Energy & Fatigue

One of the biggest blows to my whole lifestyle, both before and after chemo for lymphoma, was the fatigue (loss of energy). Sure, during chemo was the worst, with some days I was barely able to drag my butt out of bed. My wife was pregnant with our second at the time. The first time she thought she was having the baby I told her I couldn't make it I was so bad. Fortunately it was a false alarm and she was born the next week (my off chemo weekend) when I was able to get about.



Even after treatment, these 10 years, I still do not have the energy level I had years ago. Maybe part of it is old age or other physical causes. Dr. Wendy Harpham says in her book "After Cancer" that you have to establish a New Normal level and not expect life to be quite the same. Still in this rush-rush lifestyle of the 21st century we have unreasonable expectations.



I have a good page on fatigue that you might wish to read. It links to the US National Cancer Institute documents on the subject which are for both those in treatment & afterwards.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap